Naoki Hosoe

Dr. Naoki Hosoe

Center for Diagnostic and Therapeutic Endoscopy, Keio University, Tokyo, Japan
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2020 in Digestive Endoscopy
Verified
Journal Article
Open access
PDF file
TGTakuji Gotoda
Takuji Gotoda
TATakuji Akamatsu
Takuji Akamatsu
SASeiirhicro Abe
Seiirhicro Abe
MSMasaaki Shimatani
Masaaki Shimatani
YNYousuke Nakai
Yousuke Nakai
HIHaruhiro Inoue
Haruhiro Inoue
Sedation in gastroenterological endoscopy has become an important medical option in routine clinical care. Here, the Japan Gastroenterological Endoscopy Society and the Japanese Society of Anesthesiologists together provide the revised “Guidelines for sedation in gastroenterological endoscopy” as a second edition to address on‐site clinical questions and issues raised for safe examination and treatment using sedated endoscopy. Twenty clinical questions were determined and the strength of recommendation and evidence quality (strength) were expressed according to the “MINDS Manual for Guideline Development 2017.” We were able to release up‐to‐date statements related to clinical questions and current issues relevant to sedation in gastroenterological endoscopy (henceforth, “endoscopy”). There are few reports from Japan in this field (e.g., meta‐analyses), and many aspects have been based only on a specialist consensus. In the current scenario, benzodiazepine drugs primarily used for sedation during gastroenterological endoscopy are not approved by national health insurance in Japan, and investigations regarding expense‐related disadvantages have not been conducted. Furthermore, including the perspective of beneficiaries (i.e., patients and citizens) during the creation of clinical guidelines should be considered. These guidelines are standardized based on up‐to‐date evidence quality (strength) and supports on‐site clinical decision‐making by patients and medical staff. Therefore, these guidelines need to be flexible with regard to the wishes, age, complications, and social conditions of the patient, as well as the conditions of the facility and discretion of the physician.

17 January 2019 in Digestive Endoscopy
Verified
Journal Article
Closed access
PDF file
NHNaoki Hosoe
Naoki Hosoe
KTKaoru Takabayashi
Kaoru Takabayashi
HOHaruhiko Ogata
Haruhiko Ogata
TKTakanori Kanai
Takanori Kanai

1 February 2020 in Gastroenterology
Verified
Journal Article
Closed access
KKKenta Kawasaki
Kenta Kawasaki
MFMasayuki Fujii
Masayuki Fujii
SSShinya Sugimoto
Shinya Sugimoto
KIKeiko Ishikawa
Keiko Ishikawa
MMMami Matano
Mami Matano
TSToshiro Sato
Toshiro Sato

21 March 2013 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
NHNaoki Hosoe
Naoki Hosoe
KMKatsuyoshi Matsuoka
Katsuyoshi Matsuoka
MNMakoto Naganuma
Makoto Naganuma
YIYosuke Ida
Yosuke Ida
YIYuka Ishibashi
Yuka Ishibashi
THToshifumi Hibi
Toshifumi Hibi

16 June 2020 in Digestive Endoscopy
Verified
Journal Article
Open access
PDF file
NHNaoki Hosoe
Naoki Hosoe
KKKenji J. L. Limpias Kamiya
Kenji J. L. Limpias Kamiya
YHYukie Hayashi
Yukie Hayashi
TSTomohisa Sujino
Tomohisa Sujino
HOHaruhiko Ogata
Haruhiko Ogata
TKTakanori Kanai
Takanori Kanai
While both the annual incidence and mortality of colorectal cancer are slowly but steadily decreasing in the United States, the incidence of such malignancy is increasing in Japan. Thus, controlling colorectal cancer in Japan is a major concern. In 2006, colon capsule endoscopy was first introduced by Eliakim et al. First‐generation colon capsule endoscopy had a moderate sensitivity for detecting polyps of more than 6 mm. Thus, second‐generation colon capsule endoscopy was developed to achieve higher sensitivity. Colonoscopy is the gold standard tool for colorectal cancer surveillance. With an improvement in the imaging function, the performance of second‐generation colon capsule endoscopy is almost as satisfactory as that of colonoscopy. Certain situations, such as incomplete colonoscopy and contraindication for use of sedation, can benefit from colon capsule endoscopy. Colon capsule endoscopy requires a more extensive bowel preparation than colonoscopy and computed tomography colonography because it requires laxatives not only for bowel cleansing but also for promoting the excretion of the capsule. Another problem with colon capsule endoscopy includes the burden of reading and interpretation and overlook of the lesions. Currently, the development of automatic diagnosis of colon capsule endoscopy using artificial intelligence is still under progress. Although the available guidelines do not support the use of colon capsule endoscopy for inflammatory bowel disease, the possible application of colon capsule endoscopy is ulcerative colitis. This review article summarizes and focuses on the current status of colon capsule endoscopy for colorectal cancer screening and the possibility for its applicability on inflammatory bowel disease.

9 November 2022 in Digestive Endoscopy
Verified
Journal Article
Closed access
HYHironori Yamamoto
Hironori Yamamoto
TYTomonori Yano
Tomonori Yano
AAAkihiro Araki
Akihiro Araki
MEMotohiro Esaki
Motohiro Esaki
KOKazuo Ohtsuka
Kazuo Ohtsuka
HIHaruhiro Inoue
Haruhiro Inoue